Skip to content

The assessment of the effect on postoperative pain of laparoscopic cholecystectomy and common bile duct exploration using parecobix in combination with laparoscopic assisted TAP

The assessment of the effect on postoperative pain of laparoscopic cholecystectomy and common bile duct exploration using parecobix in combination with laparoscopic assisted TAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013542
Enrollment
Unknown
Registered
2017-11-25
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis

Interventions

TAP group:Parecobix combined with laparoscopic assisted TAP
Control group:Parecobix combined with local infiltration

Sponsors

Shanghai Tenth Peoples' Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients to be scheduled for elective laparoscopic cholecystectomy, common bile duct (CBD) exploration and one stage suture of CBD.

Exclusion criteria

Exclusion criteria: (1) Patients with age below 18 or over 75 years; (2) ASA status III or IV; (3) acute cholecystitis, gangrenous cholecystitis, acute cholangitis; (4) the cases were excluded if the operation was converted to an open procedure; (5) the cases with common bile duct exploration inserted a T-drainage; (6) chronic pain of any kind other than gallbladder disease; (7) patients who are allergy to the study drugs; (8) patients who have cognitive impairment or communication problems; (9) gastrointestinal disease, such as peptic ulcer; (10) patients who have severe hepatic or renal impairment.

Design outcomes

Primary

MeasureTime frame
Post-operative VAS scores;Application dosage of analgesic;

Countries

China

Contacts

Public ContactTingsong Yang

Shanghai Tenth Peoples' Hospital

tingsong.yang@outlook.com+86 021-66307363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026